Research

ONL Therapeutics Announces Formation of Scientific Advisory Board

ONL Therapeutics Announces Formation of Scientific Advisory Board

October 14, 2015

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, is one of five of the world’s premier retinal disease thought leaders who will serve on its newly formed scientific advisory board (SAB). The goal of...

Read more about ONL Therapeutics Announces Formation of Scientific Advisory Board
Jason Comander and Leo Kim discuss vision research with members of Congress

Jason Comander and Leo Kim discuss vision research with members of Congress

October 13, 2015

On October 7th and 8th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows scientists to meet with members of Congress to discuss the importance of vision research in the continuing fight to prevent blindness. 

Dr...

Read more about Jason Comander and Leo Kim discuss vision research with members of Congress
Targeting the Immune System to Prevent Vision Loss

Targeting the Immune System to Prevent Vision Loss

July 22, 2015

Vision researchers at Mass. Eye and Ear/Harvard Medical School (HMS) Department of Ophthalmology have taken a first step in solving a vexing problem: how to preserve photoreceptor cells and avoid irreversible vision loss in patients following retinal detachment. 

Degeneration of photoreceptors, the major light-sensing cells in the eye, is a primary cause of vision loss worldwide. Identifying the underlying causes surrounding photoreceptor cell death is paramount in order to develop new treatment strategies to prevent their loss. Retinal detachment and subsequent degeneration of...

Read more about Targeting the Immune System to Prevent Vision Loss
Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy

Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy

July 30, 2015

Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina. This discovery, published July 30 in Cell Reports, could potentially be used to design gene therapies that are not only safer and more potent than therapies currently...

Read more about Researchers Resurrect Ancient Viruses in Hopes of Improving Gene Therapy
Panel-based Genetic Diagnostic Testing for Eye Disease

Panel-based Genetic Diagnostic Testing for Eye Disease

December 1, 2014

Researchers Report that Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and More Sensitive than Exome Sequencing
Findings published online in Genetics in Medicine

Contact: Mary Leach 

BOSTON, MASS. (Nov. 20, 2014) --Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a...

Read more about Panel-based Genetic Diagnostic Testing for Eye Disease
New Grant for Retinal Tissue Engineering Awarded by the Bertarelli Program in Translational Neuroscience and Neuroengineering

New Grant for Retinal Tissue Engineering Awarded by the Bertarelli Program in Translational Neuroscience and Neuroengineering

October 24, 2014

Pages